The Prevalence of Hand Joint Hypermobility and Its Relationship With Grip Strength Among University Students.

by palligoelme@gmail.com | Jan 23, 2026 | Clinical Trials

​ Conditions: Hand Joint Hypermobility; Grip Strength Interventions: Other: No Interventions Sponsors: Ehab A. Abdallah; Horus University Not yet recruiting Conditions: Hand Joint Hypermobility; Grip Strength Interventions: Other: No Interventions Sponsors: Ehab A....

Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin

by palligoelme@gmail.com | Jan 23, 2026 | Clinical Trials

​ Conditions: Obesity Interventions: Drug: RAY1225; Drug: atorvastatin calcium tablet; Drug: Metformin Tablets; Drug: Warfarin Sodium Tablets; Drug: Digoxin Tablets Sponsors: Guangdong Raynovent Biotech Co., Ltd Active, not recruiting Conditions: Obesity...

Prediction of Complications in Hepatic Tumors

by palligoelme@gmail.com | Jan 22, 2026 | Clinical Trials

​ Conditions: Hepatic Tumors Interventions: Diagnostic Test: [99mTc] Tc-GSA SPECT/CT Sponsors: Rigshospitalet, Denmark; Danish Cancer Society Not yet recruiting Conditions: Hepatic Tumors Interventions: Diagnostic Test: [99mTc] Tc-GSA SPECT/CT Sponsors:...

Efficacy and Safety of TC011 in Relapsed or Refractory Follicular Lymphoma

by palligoelme@gmail.com | Jan 22, 2026 | Clinical Trials

​ Conditions: Follicular Lymphoma (FL) Interventions: Biological: TC011 single-arm Sponsors: TICAROS Co., Ltd. Not yet recruiting Conditions: Follicular Lymphoma (FL) Interventions: Biological: TC011 single-arm Sponsors: TICAROS Co., Ltd. Not yet...

A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

by palligoelme@gmail.com | Jan 22, 2026 | Clinical Trials

​ Conditions: Refractory Metastatic Colorectal Cancer Interventions: Drug: Suvemcitug injection, trifluridine/tipiracil tablets; Drug: Suvemcitug placebo injection, trifluridine/tipiracil tablets Sponsors: Jiangsu Simcere Pharmaceutical Co., Ltd.; Jiangsu Simcere...